| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000034083 |
| Receipt No. | R000038812 |
| Official scientific title of the study | Efficacy of GLP-1 receptor agonists for steroid-induced hyperglycemia in patients with diabetes |
| Date of disclosure of the study information | 2018/10/01 |
| Last modified on | 2018/09/05 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Efficacy of GLP-1 receptor agonists for steroid-induced hyperglycemia in patients with diabetes | |
| Title of the study (Brief title) | Efficacy of GLP-1 receptor agonists for steroid-induced hyperglycemia in patients with diabetes | |
| Region |
|
|
| Condition | ||
| Condition | Diabetes | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Evaluate the efficacy of GLP-1 receptor agonists as an add-on therapy to insulin for steroid-induced hyperglycemia in patients with diabetes |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Glycemic control and total daily insulin dose |
| Key secondary outcomes | Glycemic variation, adverse events including hypoglycemia, body weight, blood pressure, and lipid profile |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | treat patients with insulin | |
| Interventions/Control_2 | treat patients with insulin and GLP-1 receptor agonists | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Subjects with diabetes
2) Subjects who routinely take oral or intravenous steroids 3) Subjects who agree to participate in the study with oral and written informed consent |
|||
| Key exclusion criteria | 1) Subjects who refuse to participate in the study
2) Subjects who type 1 diabetes 3) Subjects with insulin-dependent diabetes 4) Subjects who used GLP-1 receptor agonists within one month 5) Subjects who are critically ill 6) Subjects who have difficulty participating in the study |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Akihiro Hamasaki |
| Organization | Tazuke Kofukai Medical Research Institute, Kitano Hospital |
| Division name | Center for diabetes and endocrinology |
| Address | 2-4-20 Ohgimachi, Kita-ku, Osaka, JAPAN, 530-8480 |
| TEL | 06-6312-1221 |
| a-hamasaki@kitano-hp.or.jp | |
| Public contact | |
| Name of contact person | Satoshi Yoshiji |
| Organization | Tazuke Kofukai Medical Research Institute, Kitano Hospital |
| Division name | Center for diabetes and endocrinology |
| Address | 2-4-20 Ohgimachi, Kita-ku, Osaka, JAPAN, 530-8480 |
| TEL | 06-6312-1221 |
| Homepage URL | |
| s-yoshiji@kitano-hp.or.jp | |
| Sponsor | |
| Institute | Center for diabetes and endocrinology, Tazuke Kofukai Medical Research Institute, Kitano Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Center for diabetes and endocrinology, Tazuke Kofukai Medical Research Institute, Kitano Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 公益財団法人田附興風会医学研究所 北野病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038812 |